About Intersect ENT
Intersect ENT is a company based in Menlo Park (United States) founded in 2003 was acquired by Medtronic in August 2021. Intersect ENT has raised $76.53 million across 4 funding rounds from investors including Medtronic, Kleiner Perkins and Norwest Venture Partners. The company has 371 employees. Intersect ENT has completed 1 acquisition, including Fiagon. Intersect ENT operates in a competitive market with competitors including Tivic Health, Acclarent, Entellus Medical, MyPurMist and Dalent Medical, among others.
- Headquarter Menlo Park, United States
- Employees 371
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website intersectent.com
- Social LinkedIn X Facebook
- Acquired by Medtronic (Aug 2021)
Funding Insights of Intersect ENT
Intersect ENT has successfully raised a total of $76.53M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $65 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $76.53M
- Total Rounds 4
- Last Round Post-IPO — $65M
- First Round $15.51M
(Nov 2010)
- Investors Count 6
All 4 funding rounds of Intersect ENT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
6 investors in total: 6 institutional.
Investors in Intersect ENT
Intersect ENT has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Kleiner Perkins and Norwest Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | – | deerfield.com | New York, United States | |
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors. | 1961 | nvp.com | Menlo Park, United States | |
VC firm that focuses on early stage investments in the US | – | usvp.com | Menlo Park, United States | |
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US | 2003 | ptvhc.com | Austin, United States | |
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for Intersect ENT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Intersect ENT
1083 people are tracked at Intersect ENT (413 in leadership, 11 in board & advisors, 659 in team); the tracked headcount is 371.
| Name | Role | Group |
|---|---|---|
Shannon Mays | Vice President | U.s. Commercial Strategy & Enaibled Strategic Sales | Leadership |
Brian Asmussen | Senior Director Of Enterprise Accounts & Services | Leadership |
William Albans | Senior Sales Director | Leadership |
April Francis | IT Director | Leadership |
Arvind Ramadorai | Global Head Of Innovation, Robotic Surgery Technologies | Leadership |
Steve Hartmann | Vice President R&d | Leadership |
Shane Buff | Vice President R&d Next Gen Surgical Robotics | Leadership |
Silvia Natalia Mann | VAVE Engineering Director | Leadership |
Eric Schilling | Chief Systems Engineer For Tvcpt, Distinguished Engineer, Technical Fellow | Leadership |
Roopa Sripathi | Associate Engineering Director | Leadership |
Linnea Burman | SVP & President, Neurovascular | Leadership |
Kristine Gredzens | VP Of Finance, CFO Of Peripheral Vascular Health | Leadership |
Carl Barbieri | Finance Director - Contract Manufacturing | Leadership |
Niels Huve | Senior Director APAC Deliver Operations | Leadership |
Brett Wall | EVP & President, Neuroscience Portfolio | Leadership |
Edgar Arrocha | VP Finance, CFO Cranial And Spinal Technologies Operating Unit | Leadership |
Luke S. | Director Of Finance | Leadership |
Joann Tholen | IT Program Director | Leadership |
Stephanie Vanosdall | Senior Director | Leadership |
Teresa Carrasco | Employee And Labor Relations Director | Leadership |
1063 more people are available in the full profile.
Complete people profiles for Intersect ENT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intersect ENT
Intersect ENT has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fiagon.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical navigation systems for surgical applications to healthcare providers | fiagon.com | Hennigsdorf, Germany | 2007 | Sep 2020 | $71.16M |
Complete acquisition details for Intersect ENT
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Intersect ENT
6 dated milestones of Intersect ENT across 18 years, from founding to its latest funding, stage changes and deals.
Competitors of Intersect ENT
Intersect ENT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tivic Health, Acclarent, Entellus Medical, MyPurMist and Dalent Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tivichealth.com | 2016 | Menlo Park, United States | $8M | 16 | Bioelectronic devices for sinusitis pain relief are developed. | |
| acclarent.com | 2004 | Irvine, United States | $61M | 349 | Balloon-based sinuplasty technologies are developed for ENT surgeons. | |
| entellusmedical.com | 2006 | Plymouth, United States | $90.53M | 286 | Minimally invasive products for chronic sinusitis treatment are developed. | |
| mypurmist.com | 2001 | Concord, United States | $8.89M | 5 | Medical humidification devices are developed with patented CFV technology. | |
| dalentmedical.com | 2017 | Coral Gables, United States | $3.45M | – | Balloon-based sinus dilation devices are developed for sinusitis treatment. | |
| sinusafe.com | 2015 | Kiryat Ono, Israel | – | – | Sinus lavage device for sinusitis patients is developed without surgery. | |
| jedersystem.com | 2010 | Vienna, Austria | $732,000 | – | Minimally invasive sinus lift system | |
| ststent.com | 2013 | Misgav, Israel | $450,000 | – | Flexible nasal stent | |
| bioinspiretechnologies.com | 2009 | Palo Alto, United States | $3.12M | 7 | Specializes in interventional medical devices development. |
Detailed competitors of Intersect ENT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Intersect ENT
Websites that share an audience with Intersect ENT (intersectent.com).
Websites whose visitors overlap most with Intersect ENT. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 1life.com | 100% | 2.1K | #5,669,324 | View details |
Latest news on Intersect Ent
Complete news archive for Intersect ENT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Intersect ENT
10 companies that operate in the same segment as Intersect ENT (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Intersect ENT
Intersect ENT was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Intersect ENT is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Intersect ENT is a funded company, having raised a total of $76.53M across 4 funding rounds to date. The company's 1st funding round was a Series B of $15.51M, raised on Nov 2010.
Intersect ENT has 371 employees.
Developer of a drug-releasing implant to treat sinusitis. The company has developed drug-releasing implants called CE marked and FDA-approved dissolvable implants for the treatment of chronic sinusitis called Propel, Propel Mini and PROPEL Contour. The devices consist of a spring-like implant that expands to open the ethmoid sinus and dissolves to deliver corticosteroids with anti-inflammatory properties to the sinus lining. The company claims that the device is clinically proven to prevent obstruction of the ethmoid sinus following surgery.
Intersect ENT's top competitors include Tivic Health, Entellus Medical and MyPurMist.
Intersect ENT has made 1 acquisition, including Fiagon.
Intersect ENT has 6 investors. Key investors include Medtronic, Kleiner Perkins, Norwest Venture Partners, PTV Healthcare Capital, and Deerfield.
Yes. Intersect ENT was acquired by Medtronic in August 2021.